Minjiang H. Chen

289 Kuocang Road
Lishui, 323000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 180 publications

Macrophage-reprogramming calcium alginate microspheres enhance exosome-mediated antigen cross-presentation to boost embolization-immunotherapy in hepatocellular carcinoma.

Macrophage-reprogramming calcium alginate microspheres enhance exosome-mediated antigen cross-presentation to boost embolization-immunotherapy in hepatocellular carcinoma.

Journal: Materials today. Bio

Published: April 20, 2026

Laser-programmable glycosaminoglycan-based nanocarriers co-deliver hypocrellin B and doxorubicin for spatiotemporal chemo-photothermal therapy of hepatocellular carcinoma.

Laser-programmable glycosaminoglycan-based nanocarriers co-deliver hypocrellin B and doxorubicin for spatiotemporal chemo-photothermal therapy of hepatocellular carcinoma.

Journal: Colloids and surfaces. B, Biointerfaces

Published: April 18, 2026

A novel combination therapy for effective treatment of cancer by designed anti-immunosuppressive nanoregulator and radiofrequency ablation.

A novel combination therapy for effective treatment of cancer by designed anti-immunosuppressive nanoregulator and radiofrequency ablation.

Journal: Biomaterials

Published: April 16, 2026

Towards advancing cancer nanomedicine: Recent strategies for overcoming translational and toxicological challenges.

Towards advancing cancer nanomedicine: Recent strategies for overcoming translational and toxicological challenges.

Journal: Biomaterials advances

Published: March 29, 2026

A Liposomal Nanovaccine Reprograms Post-Ablation Macrophages to Sustain Antitumor Immunity in Hepatocellular Carcinoma.

A Liposomal Nanovaccine Reprograms Post-Ablation Macrophages to Sustain Antitumor Immunity in Hepatocellular Carcinoma.

Journal: Acta biomaterialia

Published: March 22, 2026

In-Outside Hypoxia Remodeling Strategy Triggers Ferroptosis to Boost TACE Therapy in Hepatocellular Carcinoma.

In-Outside Hypoxia Remodeling Strategy Triggers Ferroptosis to Boost TACE Therapy in Hepatocellular Carcinoma.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: March 10, 2026

A flaxseed oil body-based delivery system integrating calcium overload and lipid peroxidation for immunogenic cell death-driven immunotherapy.

A flaxseed oil body-based delivery system integrating calcium overload and lipid peroxidation for immunogenic cell death-driven immunotherapy.

Journal: Materials today. Bio

Published: February 23, 2026

A Pathomics-Based Prognostic Model for Disease-Free Survival in Resected Gastric Cancer.

A Pathomics-Based Prognostic Model for Disease-Free Survival in Resected Gastric Cancer.

Journal: Cancers

Published: January 30, 2026

Multimodal MRI and machine learning for identifying depression in cerebral small vessel disease: a multicenter study.

Multimodal MRI and machine learning for identifying depression in cerebral small vessel disease: a multicenter study.

Journal: BMC medical imaging

Published: January 06, 2026

AIEgen-mediated integration of plain DNA and hydrophobic compounds enabling three-in-one nanosystems for carrier-free delivery.

AIEgen-mediated integration of plain DNA and hydrophobic compounds enabling three-in-one nanosystems for carrier-free delivery.

Journal: Journal of nanobiotechnology

Published: December 12, 2025

Corrigendum to 'Microenvironment responsive nanoplatform for targeted removal of cholesterol and reshaping inflammatory microenvironment in atherosclerotic plaques' [Journal of Controlled Release 385 (2025) 114000].

Corrigendum to 'Microenvironment responsive nanoplatform for targeted removal of cholesterol and reshaping inflammatory microenvironment in atherosclerotic plaques' [Journal of Controlled Release 385 (2025) 114000].

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: November 13, 2025

KAT2B inhibits cholangiocarcinoma proliferation by binding with histone demethylase KDM6B.

KAT2B inhibits cholangiocarcinoma proliferation by binding with histone demethylase KDM6B.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 11, 2025

Showing 1-12 of 180

Last Updated: 09/26/2026